Medicines and Poisons (Medicines) Regulation 2021
sec.233Giving chief executive information about particular diversion-risk medicines
Start here
Get a plain-English read of sec.233
Turn the raw legal text into a practical explanation grounded in Medicines and Poisons (Medicines) Regulation 2021.
sec.233 Giving chief executive information about particular diversion-risk medicines
This section applies if— a person seeks a supply of a diversion-risk medicine from a pharmacist, other than a medicine that is also a monitored medicine; and the pharmacist reasonably suspects the amount of the medicine sought exceeds the amount or frequency of doses that the person could reasonably be seeking for the therapeutic treatment of the person or the person’s animal. The pharmacist must give notice to the chief executive in the approved form unless the pharmacist has a reasonable excuse. Maximum penalty—40 penalty units. (sec.233-ssec.1) This section applies if— a person seeks a supply of a diversion-risk medicine from a pharmacist, other than a medicine that is also a monitored medicine; and the pharmacist reasonably suspects the amount of the medicine sought exceeds the amount or frequency of doses that the person could reasonably be seeking for the therapeutic treatment of the person or the person’s animal. (sec.233-ssec.2) The pharmacist must give notice to the chief executive in the approved form unless the pharmacist has a reasonable excuse. Maximum penalty—40 penalty units.
- (a) a person seeks a supply of a diversion-risk medicine from a pharmacist, other than a medicine that is also a monitored medicine; and
- (b) the pharmacist reasonably suspects the amount of the medicine sought exceeds the amount or frequency of doses that the person could reasonably be seeking for the therapeutic treatment of the person or the person’s animal.